证券记录 · 已归档季度
CRL
Charles River Laboratories International, Inc. · Healthcare · Medical - Diagnostics & Research
13被追踪持有人
-1Δ持有人
6.67M持有股份
$1.31B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -7.1% ·
股份流向 +30.0% ·
净新建仓位 -7.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 140 | -1 | 45.53M | $10.31B | +6 | −6 |
| Q1 2026 | 143 | -7 | 45.52M | $7.86B | +6 | −14 |
| Q4 2025 | 150 | +3 | 43.69M | $8.72B | +4 | — |
| Q3 2025 | 22 | 0 | 23.18M | $3.62B | +1 | −2 |
| Q2 2025 | 20 | +2 | 21.36M | $3.24B | +4 | −2 |
| Q1 2025 | 15 | 0 | 9.57M | $1.44B | +1 | −1 |
| Q4 2024 | 15 | +1 | 9.65M | $1.78B | +1 | — |
| Q3 2024 | 13 | -1 | 6.67M | $1.31B | — | −1 |
| Q2 2024 | 14 | — | 3.92M | $810.09M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.74M | +135927.9% | $736.82M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.22M | +0.1% | $239.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 1.22M | +0.1% | $239.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 526.31K | +2.4% | $103.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 309.06K | -62.6% | $60.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 309.06K | -62.6% | $60.88M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 273.62K | 0.0% | $53.89M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 184.69K | +0.9% | $36.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 172.91K | -73.0% | $34.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 172.91K | -73.0% | $34.06M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 77.38K | +51.4% | $15.24M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 18 | Baillie Gifford ✦ | 68.58K | +1.6% | $13.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 68.58K | +1.6% | $13.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 68.58K | +1.6% | $13.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 44.63K | -28.3% | $8.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 44.63K | -28.3% | $8.79M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 19.25K | +412.5% | $3.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Millennium Management ✦ | 18.14K | +60.2% | $3.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 14.20K | -50.8% | $2.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 14.20K | -50.8% | $2.80M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Adage Capital Partners | $8.73M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 555 持有人, 56.84M 股份, $9.32B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 19
Parisotto Shannon M
Officer · 2.04K 股 · $599,711
Aug 18
Andrews Nancy C
Director · 573 股 · $163,443
Aug 11
Parisotto Shannon M
Officer · 3.71K 股 · $1.04M
Aug 11
Girshick Birgit
Officer, Director · 6.50K 股 · $1.82M
Aug 10
FOSTER JAMES C
Director · 28.73K 股 · $7.90M
Aug 06
Knell Michael Gunnar
Officer · 404 股 · $104,446
Aug 06
Knell Michael Gunnar
Officer · 1.21K 股 · $311,529
Aug 06
Knell Michael Gunnar
Officer · 736 股 · $190,278
Aug 06
Creamer Victoria L
Officer · 4.18K 股 · $1.08M
Aug 06
Knell Michael Gunnar
Officer · 1.27K 股 · $330,055
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G — Invesco Ltd.
Aug 06
SC 13G/A — FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据